Delaware District Court
Judge:Sue L Robinson
Case #: 1:14-cv-01317
Nature of Suit830 Property Rights - Patent
Cause35:145 Patent Infringement
Case Filed:Oct 17, 2014
Terminated:Jan 05, 2017
Last checked: Thursday May 14, 2015 6:23 AM EDT
Defendant
Sanofi-Aventis U.S. LLC
Represented By
Steven J. Balick
Ashby & Geddes
contact info
Tiffany Geyer Lydon
Ashby & Geddes
contact info
Andrew Colin Mayo
Ashby & Geddes
contact info
Matthew Alan Pearson
Akin Gump Strauss Hauer & Feld LLP
contact info
Defendant
Aventisub LLC
Represented By
Steven J. Balick
Ashby & Geddes
contact info
Tiffany Geyer Lydon
Ashby & Geddes
contact info
Andrew Colin Mayo
Ashby & Geddes
contact info
Matthew Alan Pearson
Akin Gump Strauss Hauer & Feld LLP
contact info
Defendant
Regeneron Pharmaceuticals Inc.
Represented By
Steven J. Balick
Ashby & Geddes
contact info
Tiffany Geyer Lydon
Ashby & Geddes
contact info
Andrew Colin Mayo
Ashby & Geddes
contact info
Matthew G Hartman
contact info
Dianne B. Elderkin
contact info
Steven D. Maslowski
contact info
Angela Verrecchio
contact info
Matthew Alan Pearson
Akin Gump Strauss Hauer & Feld LLP
contact info
Defendant
Sanofi
Represented By
Steven J. Balick
Ashby & Geddes
contact info
Tiffany Geyer Lydon
Ashby & Geddes
contact info
Vishal C. Gupta
contact info
Andrew Colin Mayo
Ashby & Geddes
contact info
Siew Yen Chong
contact info
Jeffrey C. Lee
contact info
Matthew Alan Pearson
Akin Gump Strauss Hauer & Feld LLP
contact info
John J. Molenda
contact info
Plaintiff
Amgen Inc.
Represented By
Melanie K. Sharp
Young, Conaway, Stargatt & Taylor LLP
contact info
William G. Gaede, III
contact info
James L. Higgins
Young, Conaway, Stargatt & Taylor LLP
contact info


1. Judge Rules Against Sanofi and Regeneron in Patent Case (wsj.com)
Submitted Fri 01/06/2017
Docket last updated: 02/19/2017 11:59 PM EST
Thursday, February 16, 2017
misc Deficiency re Redacted Documents Thu 2:48 PM
REDACTION NOTICE: In accordance with section G of the Administrative Procedures Governing Filing and Service by Electronic Means, redacted versions of sealed documents shall be filed electronically within 7 days of the filing of the sealed document. The records of this case do not reflect the filing of a redacted version of DI # 395, 396, 397, 398, 399. (fms)
Related: [-]
Tuesday, February 14, 2017
416 416 respm Brief - Answering Brief in Opposition Tue 5:30 PM
ANSWERING BRIEF in Opposition re406 MOTION to Alter Judgment [Amgen's Motion and Memorandum to Amend Final Rule 54(b) Judgment (D.I. 391) Under Fed. R. Civ. P. 59(e) and 35 U.S.C. 284 to Include an Accounting and Enhancement Determination Following Appeal] filed by Aventisub LLC, Regeneron Pharmaceuticals Inc., Sanofi, Sanofi-Aventis U.S. LLC.Reply Brief due date per Local Rules is 2/21/2017. (Balick, Steven)
Related: [-]